Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site

Munetomo Takahashi,Tsz Y. So,Vitalina Chamberlain-Evans,Robert Hughes,Juan Carlos Yam-Puc,Katarzyna Kania,Michelle Ruhle,Tiffeney Mann,Martijn J. Schuijs,Paul Coupland,Dean Naisbitt,Timotheus Y. F. Halim,Paul A. Lyons,Pietro Lio,Rahul Roychoudhuri,Klaus Okkenhaug,David J. Adams,Ken G. C. Smith,Duncan I. Jodrell,Michael A. Chapman,James E. D. Thaventhiran
DOI: https://doi.org/10.1126/sciimmunol.ade2094
IF: 30.63
2024-05-26
Science Immunology
Abstract:Immunotherapy advances have been hindered by difficulties in tracking the behaviors of lymphocytes after antigen signaling. Here, we assessed the behavior of T cells active within tumors through the development of the antigen receptor signaling reporter (AgRSR) mouse, fate-mapping lymphocytes responding to antigens at specific times and locations. Contrary to reports describing the ready egress of T cells out of the tumor, we find that intratumoral antigen signaling traps CD8 + T cells in the tumor. These clonal populations expand and become increasingly exhausted over time. By contrast, antigen-signaled regulatory T cell (T reg ) clonal populations readily recirculate out of the tumor. Consequently, intratumoral antigen signaling acts as a gatekeeper to compartmentalize CD8 + T cell responses, even within the same clonotype, thus enabling exhausted T cells to remain confined to a specific tumor tissue site.
immunology
What problem does this paper attempt to address?